Andrew R Jordan is CHIEF STRATEGY OFFICER of IDERA PHARMACEUTICALS, INC.. Currently has a direct ownership of 451,890 shares of IDRA, which is worth approximately $1.36 Million. The most recent transaction as insider was on Jan 17, 2023, when has been sold 402,529 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 452K
0% 3M change
0% 12M change
Total Value Held $1.36 Million

ANDREW R JORDAN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 17 2023
BUY
Exercise of conversion of derivative security
-
402,529 Added 47.11%
451,890 Common Stock
Jan 06 2023
SELL
Payment of exercise price or tax liability
$52,497 $0.71 p/Share
73,940 Reduced 8.1%
839,142 Common Stock
Jan 06 2023
BUY
Grant, award, or other acquisition
-
261,718 Added 22.28%
913,082 Common Stock
Sep 28 2022
BUY
Grant, award, or other acquisition
-
651,364 Added 50.0%
651,364 Common Stock, par valu...
ARJ

Andrew R Jordan

CHIEF STRATEGY OFFICER
Exton, PA

Track Institutional and Insider Activities on IDRA

Follow IDERA PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IDRA shares.

Notify only if

Insider Trading

Get notified when an Idera Pharmaceuticals, Inc. insider buys or sells IDRA shares.

Notify only if

News

Receive news related to IDERA PHARMACEUTICALS, INC.

Track Activities on IDRA